Non-Driver NSCLC: Practice Considerations

Video

Non-Driver NSCLC: Practice Considerations

  • A 72-year old male presented with dyspnea, weight loss, chronic cough, fatigue, and back pain
  • PMH: current non-smoker for the past 10 years with 40-year (1-pack/day) smoking history, COPD, controlled on LABA/LAMA/ICS; hyperlipidemia controlled on atorvastatin
  • Chest CT scan showed a 3.5-cm nodule in the upper lobe of the left lung
  • MRI of the brain revealed lesions in the left cerebellum and left frontal lobe
  • 99mTc bone scan showed increased uptake in the L1 vertebra and eighth rib
  • ECOG PS=1
  • Pathologic diagnosis of biopsy under bronchoscopy was squamous cell carcinoma
  • IHC: PD-L1 expression in 0% of cells
  • Patient was started on gemcitabine/cisplatin
  • Brain metastases treated with stereotactic radiotherapy
  • At 6 months, patient reported worsening fatigue
  • Follow up MRI scan showed no evidence of new brain metastases
  • CT scan showed new lesions in the right lung and liver
  • Patient was started on atezolizumab; ICS medication for COPD was discontinued
  • Patient reported decreased appetite, which resolved following implementation of self-management techniques
Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
Related Content